Metformin in Stage IV Lung Adenocarcinoma

Summary

The purpose of this study is to determine whether metformin is effective in lowering plasma IL-6 level and improving the treatment response in patients with non-small cell lung cancer

Timeline

Start

2013-08

Primary completion

2016-06

Completion

2016-06

Outcome

Outcome not reported

Stopped (Enrollment): “Difficult enrollment”

Drugs

Indications